India GlycolsBOM:500201 +4.80%66 Net Margin % is 8.90% as of Mar. 2026, which is 76% above its 10-year median of 5.07. GuruFocus rates BOM:500201 with a GF Score™ of 66/100 and a GF Value™ of ₹752.37 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 1,580 Chemicals companies, India Glycols ranks better than 65.76% on this metric.
Net margin is calculated as Net Income divided by its Revenue. India Glycols's Net Income for the
three
months ended in Mar. 2026 was ₹869 Mil. India Glycols's Revenue for the
three
months ended in Mar. 2026 was ₹9,764 Mil. Therefore, India Glycols's net margin for the quarter that ended in Mar. 2026 was 8.90%.
The historical rank and industry rank for India Glycols's Net Margin % or its related term are showing as below:
BOM:500201'
s Net Margin % Range Over the Past 10 Years
Min: 1.42 Med: 5.07 Max: 12.08
Current: 6.95
BOM:500201's Net Margin % is ranked better than 65.76% of 1580
companies
in the Chemicals industry
Industry Median: 3.905
vs BOM:500201: 6.95
India Glycols (BOM:500201) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
India Glycols Net Margin % Related Terms
India Glycols Net Margin % Historical Data
* Premium members only.
The historical data trend for India Glycols's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, India Glycols's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
India Glycols Net Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, India Glycols's Net Margin % distribution charts can be found below:
* The bar in red indicates where India Glycols's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
India Glycols (BOM:500201) has a Net Margin % of 8.90% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on India Glycols and its competitors. This is 76% above median its historical median of 5.07. Over the past decade, India Glycols' Net Margin % has ranged from 1.42 to 12.08. According to the industry distribution chart, India Glycols ranks #541 out of 1580 companies in the Chemicals industry, placing it in the top 34.2%.
Is India Glycols' Net Margin % too high?
India Glycols' current Net Margin % of 8.90% is 76% above median its 10-year median of 5.07. Over the past 10 years, this metric has ranged from a low of 1.42 to a high of 12.08. The Chemicals industry median Net Margin % is 3.91. India Glycols' value of 8.90% is 127.9% above this industry median. Based on the distribution chart, India Glycols ranks #541 out of 1580 companies in the Chemicals industry, which is above the industry midpoint. Overall, India Glycols has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does India Glycols' Net Margin % compare to DOW?
According to the Chemicals industry distribution chart, India Glycols ranks #541 out of 1580 companies for Net Margin %. This puts India Glycols in the upper half of its industry. The industry median Net Margin % is 3.91. India Glycols' value of 8.90% is 127.9% above this benchmark. Historically, India Glycols' own Net Margin % has ranged from 1.42 to 12.08 over the past decade. While the company's 10-year median is 5.07 vs. the industry median of 3.91, India Glycols has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Chemicals company?
The median Net Margin % among Chemicals companies is 3.91, based on 1,580 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. India Glycols's current Net Margin % of 8.90% is 127.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on India Glycols and its competitors. For the Chemicals industry, the median Net Margin % is 3.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. India Glycols's current Net Margin % is 8.90%, which is 76% above median its own 10-year median of 5.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is India Glycols stock overvalued right now?
Based on GuruFocus' analysis, India Glycols (BOM:500201) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹752.37, compared to a current price of ₹1,076.15 — trading 43% above its estimated fair value. The current Net Margin % is 8.90%, which is 76% above median its 10-year median of 5.07 and 127.9% above the Chemicals industry median of 3.91. India Glycols' overall GF Score™ is 66/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For India Glycols (BOM:500201), the current Net Margin % is 8.90% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is India Glycols (BOM:500201) Overvalued in 2026?
Based on GuruFocus' analysis, India Glycols stock appears to be overvalued.
The current stock price of ₹1,076.15 is trading 43% above its estimated GF Value™ of ₹752.37.
GuruFocus considers India Glycols to be Significantly Overvalued.
Key valuation signals for BOM:500201:
Net Margin %: 8.90% (76% above median its 10-year median of 5.07)
GF Value™: ₹752.37 vs. price of ₹1,076.15 (43% above fair value)
Industry Position: 127.9% above the Chemicals median (#541 of 1580)
No single metric tells the full story. See the BOM:500201 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
India Glycols Ltd is engaged in the manufacture of Bio-Based Specialities and Performance Chemicals, such as green technology-based bulk products, natural gums, and industrial gases; Potable Spirits, and Ennature Biopharma. The company operates through industries of Pharma & Healthcare, Oil & Gas, Textile, Food Ingredients, Automotive, Packaging, Personal Care, Potable Spirits, and Industrial and Manufacturing. Its operating segments are Bio-based Specialities and Performance Chemicals comprise Glycols, Specialty Chemicals, Natural Gum & other related goods, etc; Potable Spirits comprises the manufacture and sale of Ethyl Alcohol (Potable); Ennature Biopharma comprises the manufacture and sale of Nutraceutical Products; and Bio-fuel comprises Ethanol, DDGS & DWGS.
66GF Score
Get the complete analysis for BOM:500201
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500201 has been successfully added to your 
